Lista de obras - Montse Sanchez-Cespedes - Dominio Público Uruguay

A DNA methylation fingerprint of 1628 human samples

artículo científico publicado en 2011

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

article

A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.

artículo científico publicado en 2010

A gene-alteration profile of human lung cancer cell lines.

artículo científico publicado en 2009

Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

artículo científico publicado en 2009

An efficient expression system for the production of functionally active human LKB1.

artículo científico publicado en 2005

BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.

artículo científico publicado en 2009

Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.

artículo científico publicado en 2016

Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.

artículo científico publicado en 2004

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

artículo científico publicado en 2006

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients

scientific article published on 01 January 1998

Dissecting the genetic alterations involved in lung carcinogenesis.

artículo científico publicado en 2003

Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.

artículo científico publicado en 2004

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

artículo científico publicado en 2006

Epigenetic disruption of cadherin-11 in human cancer metastasis.

artículo científico publicado en 2012

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

artículo científico publicado en 2006

Expression inactivation of SMARCA4 by microRNAs in lung tumors

artículo científico publicado en 2014

Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.

artículo científico publicado en 2010

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

artículo científico publicado en 2004

Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer

artículo científico publicado en 2017

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

artículo científico publicado en 2017

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells

artículo científico publicado en 2017

Identification of mtDNA mutations in human cancer

scientific article published on 01 January 2002

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

scientific article published on 01 October 1999

Lung cancer biology: a genetic and genomic perspective.

artículo científico publicado en 2009

MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1

artículo científico publicado en 2014

MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells

artículo científico publicado en 2016

Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors

artículo científico publicado en 2010

Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene

artículo científico publicado en 2004

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

artículo científico publicado en 2015

Prognostic value of KIT expression in small cell lung cancer

artículo científico publicado en 2007

Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.

artículo científico publicado en 2016

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

artículo científico publicado en 2016

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis

artículo científico publicado en 1997

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

artículo científico publicado en 2009

The role of LKB1 in lung cancer ⬇️

artículo científico publicado el 1 de septiembre de 2011

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

artículo científico publicado en 2012

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

artículo científico publicado en 2010

Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.

artículo científico publicado en 2005

UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.

artículo científico publicado en 2012

VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.

artículo científico publicado en 2006

Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung.

artículo científico publicado en 2006

[Prognostic value study of lung cancer molecular markers]

scientific article published on 14 April 2009

beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters

scientific article published on 01 December 2005

Lista de obras de Montse Sanchez-Cespedes

A DNA methylation fingerprint of 1628 human samples

A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer

A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.

A gene-alteration profile of human lung cancer cell lines.

Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

An efficient expression system for the production of functionally active human LKB1.

BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.

Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.

Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients

Dissecting the genetic alterations involved in lung carcinogenesis.

Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.

Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.

Epigenetic disruption of cadherin-11 in human cancer metastasis.

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

Expression inactivation of SMARCA4 by microRNAs in lung tumors

Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer.

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells

Identification of mtDNA mutations in human cancer

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

Lung cancer biology: a genetic and genomic perspective.

MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1

MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells

Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors

Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene

PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Prognostic value of KIT expression in small cell lung cancer

Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis

The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer

The role of LKB1 in lung cancer ⬇️

The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.

UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status.

VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma.

Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung.

[Prognostic value study of lung cancer molecular markers]

beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters